| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.98B | +14.7% |
| R&D Expense | $6.0M | +0.0% |
| SG&A Expense | $638.0M | +7.4% |
| Operating Income | $1.11B | +75.8% |
| Pre-tax Income | $1.23B | +78.5% |
| Income Tax | $329.0M | +58.9% |
| Net Income | $827.0M | +87.1% |
| EPS (Basic) | $1.99 | +89.5% |
| EPS (Diluted) | $1.97 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.13B | -0.2% |
| Short-term Investments | $1.47B | -27.2% |
| Accounts Receivable | $68.0M | +6.3% |
| Inventory | $424.0M | +1.7% |
| Current Assets | $3.43B | -12.9% |
| Total Assets | $12.03B | +1.7% |
| Current Liabilities | $2.42B | +11.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.47B | +4.2% |
| Capital Expenditures | $710.0M | +4.6% |
| Investing Cash Flow | -$743.0M | -42.3% |
| Financing Cash Flow | -$716.0M | +15.2% |
| Free Cash Flow | $763.0M | +4.0% |
| +89.4% |
| Total Liabilities |
| $4.91B |
| +5.3% |
| Stockholders' Equity | $6.41B | -1.2% |